EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference

Rhea-AI Summary

EDAP TMS (Nasdaq: EDAP), a leader in robotic energy-based therapies, announced its participation in the Piper Sandler 36th Annual Healthcare Conference in New York City. CEO Ryan Rhodes will engage in a fireside discussion and conduct one-on-one investor meetings during the event, scheduled for December 3-5, 2024. The fireside chat is set for Tuesday, December 3rd, from 4:00-4:25 PM EST. Both live and archived webcasts will be available through the company's investor relations website section.

News Market Reaction – EDAP

+1.69%

1 alert

+1.69% News Effect

On the day this news was published, EDAP gained 1.69%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

        

LYON, France, November 27, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer of EDAP TMS, is scheduled to participate in a fireside discussion and host 1x1 investor meetings at the upcoming Piper Sandler 36^th Annual Healthcare Conference, which is taking place from December 3-5, 2024, in New York City.

Presentation Details:

Piper Sandler 36^th Annual Healthcare Conference

Format:        Fireside Discussion

Date:           Tuesday, December 3^rd

Time:            4:00-4:25 PM EST

Location:       New York City

  

The live and archived webcast of the presentations can be accessed in the Investors section of the Company’s website here.

About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One^® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith^® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

FAQ

When is EDAP presenting at the Piper Sandler Healthcare Conference 2024?

EDAP is scheduled to present on Tuesday, December 3rd, 2024, from 4:00-4:25 PM EST in New York City.

What type of presentation will EDAP (NASDAQ: EDAP) give at the Piper Sandler conference?

EDAP will participate in a fireside discussion format and host one-on-one investor meetings.

How can investors watch EDAP's presentation at the Piper Sandler Healthcare Conference?

Investors can access both the live and archived webcast of the presentation through the Investors section of EDAP's company website.

Who will represent EDAP at the Piper Sandler Healthcare Conference 2024?

Ryan Rhodes, Chief Executive Officer of EDAP TMS, will represent the company at the conference.